Buy Voyager Therapeutics Stock | VYGR Stock Price & Latest News | Public.com
VYGR

Voyager Therapeutics

$0.00 (0.00%)Today
    View Voyager Therapeutics (VYGR) stock trends here

    About VYGR

    Voyager Therapeutics, Inc. operates as a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    2.27
    1.29
    0.31
    -0.67
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.67

    Actual EPS
    Q1 2021

    Stats

    Market Cap$209,05M
    Volume627
    Price-to-Earnings Ratio5.36
    Dividend Rate
    Dividend Yield
    1 Year High$14.62
    1 Year Low$5.37
    Open$5.51
    High$5.75
    Low$5.37

    Buy any stock with any amount of money.

    Download the App
    Download the app